Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Sleep Med. 2018 Jul 29;51:171–178. doi: 10.1016/j.sleep.2018.06.021

Table 1.

Sample Characteristics (N = 81)

M ± SD
Age 15.00 ± 1.08
Estimated IQa 103.47 ± 12.21
N (%)
Sex
 Male 56 (69.1%)
 Female 25 (30.9%)
Race/Ethnicity
 White 63 (77.8%)
 Black 8 (9.9%)
 Asian 1 (1.2%)
 Hispanic 1 (1.2%)
 Multiracial 8 (9.9%)
Stimulant medication use 29 (35.8%)
Family Incomeb
 Up to $20,000 3 (3.8%)
 $20,001 - $40,000 9 (11.3%)
 $40,001 - $60,000 12 (15.0%)
 $60,001 - $80,000 9 (11.3%)
 Over $80,000 47 (58.8%)
Psychiatric Diagnosesc Parent Interview / Adolescent Interview / “Or” Rule
 ADHD 81 (100%) / 50 (61.7%) / 81 (100%)
  Combined Type 19 (23.5%) / 12 (14.8%) / n/a
  Inattentive Type 62 (76.5%) / 38 (46.9%) / n/a
 Depression/Dysthymia 2 (2.5%) / 1 (1.2%) / 2 (2.5%)
 Generalized Anxiety Disorder 3 (3.7%) / 5 (6.2) / 7 (8.6%)
 PTSD 1 (1.2%) / 1 (1.2%) / 2 (2.5%)
 ODD 8 (9.9%) / 2 (2.5%) / 8 (9.9%)
 CD 1 (1.2%) / 1 (1.2%) / 1 (1.2%)
 Any Comorbid Diagnosis 12 (14.8%) / 8 (9.9%) / 15 (18.5%)

Note. ADHD = attention-deficit/hyperactivity disorder. CD = conduct disorder. ODD = oppositional defiant disorder. PTSD = posttraumatic stress disorder.

a

Estimated intelligence quotient (IQ) determined using the Kaufman Brief Intelligence Scale, Second Edition (KBIT-2).

b

One parent declined to answer the family income question.

c

Diagnoses established using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS), with ADHD diagnosis based on interview with the adolescent’s parent used for study inclusion.